The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca The Peptide Boom Is Getting Out of Hand The Atlantic Peptide Therapy Prescription in 2025: Your Safe Guide